Faeth Therapeutics, Inc. - Common Stock (NQ:FTH)

27.73 -0.62 (-2.18%)

Delayed Quote Updated: 1:50 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Faeth Therapeutics, Inc. - Common Stock

Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors

September 17, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026

September 08, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics to Participate in Upcoming September Investor Conferences

September 01, 2026

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 28, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer

August 17, 2026

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments

August 14, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 07, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference

August 07, 2026

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates

August 04, 2026

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 23, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 03, 2026

From Faeth Therapeutics, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.